StockNews.com assumed coverage on shares of Patterson Companies (NASDAQ:PDCO – Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the stock.
Patterson Companies Price Performance
NASDAQ:PDCO opened at $31.33 on Tuesday. Patterson Companies has a 52 week low of $19.45 and a 52 week high of $31.79. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The firm’s 50-day simple moving average is $31.21 and its 200 day simple moving average is $28.64. The firm has a market cap of $2.77 billion, a price-to-earnings ratio of 18.32, a P/E/G ratio of 2.71 and a beta of 0.73.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of PDCO. Curat Global LLC acquired a new position in shares of Patterson Companies in the 1st quarter valued at approximately $25,000. Harbour Investments Inc. bought a new position in Patterson Companies in the fourth quarter valued at approximately $26,000. Huntington National Bank raised its position in Patterson Companies by 54.0% during the fourth quarter. Huntington National Bank now owns 1,115 shares of the company’s stock valued at $34,000 after purchasing an additional 391 shares in the last quarter. GAMMA Investing LLC lifted its stake in Patterson Companies by 103.0% during the fourth quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock worth $41,000 after purchasing an additional 680 shares during the last quarter. Finally, Quadrant Capital Group LLC increased its stake in shares of Patterson Companies by 501.6% in the 4th quarter. Quadrant Capital Group LLC now owns 1,883 shares of the company’s stock valued at $58,000 after purchasing an additional 1,570 shares during the last quarter. Institutional investors and hedge funds own 85.43% of the company’s stock.
About Patterson Companies
Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.
Further Reading
- Five stocks we like better than Patterson Companies
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- IBM’s AI Offensive: Assessing IBM’s Path to Renewed Growth
- Where to Find Earnings Call Transcripts
- Rockwell Automation: Tailwinds From Onshoring U.S. Production
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Is Energy Transfer Undervalued or a Value Trap?
Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.
